Active, Not Recruiting
A Study of Toripalimab in Adjuvant Therapy After Resection of High-risk Renal Cancer
NCT06584435
- Conditions
- High-risk Renal Cell Carcinoma
- Locations
-
- Changyi Quan Tianjin, Tianjin Municipality, China